iCAD, Inc. (ICAD)

1.4700 -0.0200 (-1.34%) 收市：04:00PM EDT

iCAD, Inc.

98 Spit Brook Road
Suite 100
Nashua, NH 03062
United States
603 882 5200
https://www.icadmed.com

版塊: Healthcare
行業: Medical Devices
全職員工: 67

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Dana R. Brown	President, CEO & Executive Chair	327.95k	無	1965
Mr. Eric Lonnqvist	Chief Financial Officer	302.6k	無	無
Mr. Jonathan Go	Chief Technology Officer	351.49k	無	1963
Ms. Michelle Strong	Chief Operations Officer	無	無	無
Ms. Annette L. Heroux	Vice President of Administration	174.9k	無	1957
Brian Testa	Chief People Officer	無	無	無
Mr. Bill Keyes	Senior VP of Global Sales Operations	無	無	無
Mr. Vasu Avadhanula	Chief Product Officer	無	無	無
Mr. Peter Graham	Senior VP of North American Sales	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

公司管治

截至 2024年5月1日 止，iCAD, Inc. 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中：9；董事會：5；股東權利：3；現金賠償：6。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。